Biocon Q4 net profit up 25% to Rs 101 cr

Biotechnology major Biocon on Thursday reported a growth of 25.04 per cent in consolidated net profit to Rs 100.81 crore for the fourth quarter ended March 31, 2011.

The company had posted a net profit of Rs 80.62 crore for the same period last year, Biocon said in a filing to the Bombay Stock Exchange (BSE).

Total income of the company also grew to Rs 703.23 crore in the January-March quarter from Rs 658.21 crore in the same period last year, it added. For the full-year ended March 31, the Bangalore-based company's net profit rose to Rs 367.52 crore from Rs 293.25 crore in the same period a year ago.

FROM THE NEWS: Q3 result  | Q2 result Biocon to invest $161 million in Malaysian unit Know the leader: Kiran Majumdar Shaw

The board of directors of the company has declared an interim dividend of 30 per cent (Rs 1.50 per share) and a final dividend of 60 per cent (Rs 3.00 per share) has also been proposed by the board, subject to the approval of the members - taking the total dividend for the year to 90 per cent (Rs 4.50 per share) on the share capital of the company.

Meanwhile, shares of the company were trading at Rs 379.95, down 1.26 per cent from the previous close on the Bombay Stock Exchange.